| 臺大學術典藏 |
2017 |
Best Practices in Global Health Practicums: Recommendations from the Association of Pacific Rim Universities
|
Withers, M. ; Li, M. ; Manalo, G. ; So, S. ; Wipfli, H. ; Khoo, H.E. ; Wu, J.T.-S. ; Lin, H.-H.; HSIEN-HO LIN |
| 國立成功大學 |
2016-11 |
Best practices in L2 English source use pedagogy: A thematic review and synthesis of empirical studies
|
Liu, Gi-Zen; Lin, Vivieri; Kou, Xiaojing; Wang, Hong-You |
| 元智大學 |
2013-12-15 |
Best Practices in Managing Social Media for Business
|
Celeste See-Pui Ng; Wang, William Yu-Chung |
| 淡江大學 |
2007 |
Best practices in school effectiveness and improvement: the case of Taiwan
|
Pan, H. L. |
| 元智大學 |
2003-02 |
Best Practices in the Management of SAP Maintenance and Upgrade
|
吳思佩 |
| 臺大學術典藏 |
2019 |
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
|
SHU-CHEN WEI; Ooi C.J.; Hilmi I.; Banerjee R.; Chuah S.W.; Ng S.C.; Geary R.; Ouyang Q.; Hisamatsu T.; Yang S.K.; Limsrivilai J.; Mustaffa N.; Makharia G.K.; Pisespongsa P.; Chen M.H.; Ran Z.H.; Ye B.D.; Park D.I.; Ling K.L.; Ong D.; Ahuja V.; Goh K.L.; Sollano J.; Lim W.C.; Leung W.K.; Ali R.A.R.; Wu D.C.; Ong E.; Colitis; Asian Organization for Crohn's; De Silva J.H.; Rerknimitr R.; Simadibrata M.; Abdullah M.; Leong R.W.L.; on behalf of the Asia-Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease |
| 臺大學術典藏 |
2021-06-15T03:11:54Z |
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
|
Ooi C.J.; Hilmi I.; Banerjee R.; Chuah S.W.; Ng S.C.; SHU-CHEN WEI; Makharia G.K.; Pisespongsa P.; Chen M.H.; Ran Z.H.; Ye B.D.; Park D.I.; Ling K.L.; Ong D.; Ahuja V.; Goh K.L.; Sollano J.; Lim W.C.; Leung W.K.; Ali R.A.R.; Wu D.C.; Ong E.; Mustaffa N.; Limsrivilai J.; Hisamatsu T.; Yang S.K.; Ouyang Q.; Geary R.; De Silva J.H.; Rerknimitr R.; Simadibrata M.; Abdullah M.; Leong R.W.L.; on behalf of the Asia-Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease; Asian Organization for Crohn's; Colitis |
| 臺大學術典藏 |
2021-06-15T03:11:54Z |
Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
|
Ooi C.J.; Hilmi I.; Banerjee R.; Chuah S.W.; Ng S.C.; SHU-CHEN WEI; Makharia G.K.; Pisespongsa P.; Chen M.H.; Ran Z.H.; Ye B.D.; Park D.I.; Ling K.L.; Ong D.; Ahuja V.; Goh K.L.; Sollano J.; Lim W.C.; Leung W.K.; Ali R.A.R.; Wu D.C.; Ong E.; Mustaffa N.; Limsrivilai J.; Hisamatsu T.; Yang S.K.; Ouyang Q.; Geary R.; De Silva J.H.; Rerknimitr R.; Simadibrata M.; Abdullah M.; Leong R.W. |
| 國立成功大學 |
2009-06-17 |
Best Practice實證醫學資料庫試用活動
|
崑巖醫學圖書分館 |
| 淡江大學 |
2010-10 |
Best Predictor of English Vocabulary Learning Among Taiwanese Young Learners
|
薛玉政 |
| 淡江大學 |
2007-11 |
Best predictor of word learning in EFL children
|
Sieh, Yu-cheng |
| 臺大學術典藏 |
2018-09-10T18:05:25Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non-Small-cell Lung Cancer Patients
|
Wu, T.-H. and Hsiue, E.H.C. and Lee, J.-H. and Lin, C.-C. and Liao, W.-Y. and Ho, C.-C. and Shih, J.-Y. and Yu, C.-J. and Yang, J.C.H.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-05-26T09:26:28Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non?�Small-cell Lung Cancer Patients
|
Wu T.-H; Hsiue E.H.-C; Lee J.-H; Lin C.-C; Liao W.-Y; Ho C.-C; Shih J.-Y; Yu C.-J; CHIH-HSIN YANG; Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Ho C.-C;Liao W.-Y;Lin C.-C;Lee J.-H;Hsiue E.H.-C;Wu T.-H |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.-H.; Liao W.-Y.; Lin C.-C.; Lee J.-H.; Hsiue E.H.-C.; Wu T.-H.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Liao W.-Y.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:06Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Shih J.-Y.; Ho C.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Wei-Yu Liao;Ho C.-C.;Shih J.-Y.;Yu C.-J.;Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; WEI-YU LIAO; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-07-21T06:46:18Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-12T02:50:39Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Lee J.-H.; Lin C.-C.; Liao W.-Y.; CHAO-CHI HO; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.; Wu T.-H.; Hsiue E.H.-C.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Liao W.-Y.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T07:00:01Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; Lee J.-H.; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; CHONG-JEN YU; Yang J.C.-H. |
| 臺大學術典藏 |
2020-05-25T07:35:11Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H; Hsiue E.H.-C; Lee J.-H; Chia-Chi Lin; Liao W.-Y; Ho C.-C; Shih J.-Y; Yu C.-J; Yang J.C.-H. |
| 臺大學術典藏 |
2021-07-13T06:04:32Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; LEE JIH-HSIANG; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 中華大學 |
2012 |
Best Value or Lowest Bid? A Quantitative Perspective
|
余文德; Yu, Wen-der |
| 國立交通大學 |
2015-05-01T11:01:45Z |
BEST WISHES TO MR. H. H. LING
|
趙曾珏 |
| 臺大學術典藏 |
2020-02-26T01:37:15Z |
Best-compromise between mechanical energy expenditure and foot clearance predicts leading limb motion during obstacle-crossing
|
Lu, T.-W.; Chen, S.-C.; Chiu, H.-C.; TUNG-WU LU |
| 臺大學術典藏 |
2022-01-22T00:04:33Z |
Best-Compromise Control Strategy Between Mechanical Energy Expenditure and Foot Clearance for Obstacle-Crossing in Older Adults: Effects of Tai-Chi Chuan Practice
|
Kuo, Chien Chung; Chen, Sheng Chang; Wang, Jr Yi; Ho, Tsung Jung; TUNG-WU LU |
| 臺大學術典藏 |
2022-03-22T08:34:36Z |
Best-Compromise Control Strategy Between Mechanical Energy Expenditure and Foot Clearance for Obstacle-Crossing in Older Adults: Effects of Tai-Chi Chuan Practice
|
Kuo C.-C;Chen S.-C;Wang J.-Y;Ho T.-J;Lu T.-W.; Kuo C.-C; Chen S.-C; Wang J.-Y; Ho T.-J; Lu T.-W.; TUNG-WU LU |
| 臺大學術典藏 |
2022-03-22T08:31:31Z |
Best-Compromise Control Strategy Between Mechanical Energy Expenditure and Foot Clearance for Obstacle-Crossing in Older Adults: Effects of Tai-Chi Chuan Practice
|
Kuo C.-C;Chen S.-C;Wang J.-Y;Ho T.-J;Lu T.-W.; Kuo C.-C; Chen S.-C; Wang J.-Y; Ho T.-J; Lu T.-W.; TUNG-WU LU |
| 臺大學術典藏 |
2022-03-22T08:34:35Z |
Best-Compromise Control Strategy Between Mechanical Energy Expenditure and Foot Clearance for Obstacle-Crossing in Older Adults: Effects of Tai-Chi Chuan Practice
|
Kuo C.-C;Chen S.-C;Wang J.-Y;Ho T.-J;Lu T.-W.; Kuo C.-C; Chen S.-C; Wang J.-Y; Ho T.-J; Lu T.-W.; TUNG-WU LU |
| 國立政治大學 |
2002-09 |
Best-path planning for public transportation systems
|
劉昭麟 |
| 淡江大學 |
2006-10 |
Bestandsaufnahme zur gegenwaertigen Situation des DaF an der TKU
|
魏榮治 |
| 臺大學術典藏 |
2018-09-10T07:24:14Z |
Bet 1: Steroids for patients with vestibular neuronitis
|
Chou, H.-C. and Yen, Z.-S.; ZUI-SHEN YEN |
| 臺大學術典藏 |
2020-03-19T04:29:12Z |
Bet 1: Steroids for patients with vestibular neuronitis
|
Chou H.-C.; ZUI-SHEN YEN |
| 國立臺灣大學 |
2014 |
beta 1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells
|
Che, Mei-Ieng; Huang, John; Hung, Ji-Shiang; Lin, Yo-Chuen; Huang, Miao-Juei; Lai, Hong-Shiee; Hsu, Wen-Ming; Liang, Jin-Tung; Huang, Min-Chuan; 許文明; 黃敏銓; 洪基翔; 賴鴻緒; 梁金銅; 黃約翰 |
| 國立臺灣海洋大學 |
2016-10 |
Beta 1,3/1,6-glucan and vitamin C immunostimulate the non-specific immune response of white shrimp (Litopenaeus vannamei)
|
Yu-Sheng Wu;Shu-Yu Liau;Cheng-Ting Huang;Fan-Hua Nan |
| 國立臺灣大學 |
2007 |
Beta 1,4-N-Acetylgalactosaminyltransferase Iii Enhances Malignant Phenotypes of Colon Cancer Cells
|
黃約翰; 梁金銅; 黃秀琴; 沈湯龍; 陳曉雨; 林維洲; 黃敏銓; HUANG, JOHN; LIANG, JIN-TUNG; HUANG, HSIU-CHIN; SHEN, TANG-LONG; CHEN, HSIAO-YU; LIN, WEI-CHOU; HUANG, MIN-CHUAN; HUANG, MIN- CHUAN |
| 國立臺灣大學 |
2007 |
BETA 1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE III ENHANCES MALIGNANT PHENOTYPES OF COLON CANCER CELLS
|
黃約翰; 梁金銅; 黃秀琴; 沈湯龍; 陳曉雨; 林能裕; 謝美英; 林維洲; 黃敏銓 |
| 國立臺灣大學 |
2011 |
Beta 18b-Glycyrrhetinic Acid Derivatives Induced Mitochondrial-Mediated Apoptosis through Reactive Oxygen Species-Mediated P53 Activation in Ntub1 Cells
|
林凱偉; 黃阿梅; 侯自銓; 楊世群; 蒲永孝; 林忠男; LIN, KAI-WEI; HUANG, A-MEI; HOUR, TZYH-CHYUAN; YANG, SHYH-CHYUN; PU, YEONG-SHIAU; LIN, CHUN-NAN |
| 國立成功大學 |
2009-11-15 |
beta 2 Adrenergic Receptor Activation Induces Microglial NADPH Oxidase Activation and Dopaminergic Neurotoxicity Through an ERK-Dependent/Protein Kinase A-Independent Pathway
|
Qian, Li; Hu, Xiaoming; Zhang, Dan; Snyder, Amanda; Wu, Hung-Ming; Li, Yachen; Wilson, Belinda; Lu, Ru-Band; Hong, Jau-Shyong; Flood, Patrick M. |
| 國立成功大學 |
2011-04-01 |
beta 2-Adrenergic Receptor Activation Prevents Rodent Dopaminergic Neurotoxicity by Inhibiting Microglia via a Novel Signaling Pathway
|
Qian, Li; Wu, Hung-ming; Chen, Shih-Heng; Zhang, Dan; Ali, Syed F.; Peterson, Lynda; Wilson, Belinda; Lu, Ru-Band; Hong, Jau-Shyong; Flood, Patrick M. |
| 國立臺灣大學 |
2001 |
Beta 2-Agonist Exerts Differential Effects on the Development of Cord Blood T Cells but Not on Peripheral Blood T Cells
|
楊曜旭; 林于粲; 盧孟佑; 江伯倫; YANG, YAO-HSU; LIN, YU-TSAN; LU, MENG-YAO; CHIANG, BOR-LUEN |
| 國立臺灣大學 |
2015 |
beta 2-Glycoprotein I-Dependent Anti-Cardiolipin Antibodies Associated With Periodontitis in Patients With Systemic Lupus Erythematosus
|
Wang, Chen-Ying; Chyuan, I-Tsu; Wang, Ya-Li; Kuo, Mark Yen-Ping; Chang, Ching-Wen; Wu, King-Jean; Hsu, Ping-Ning; Nagasawa, Toshiyuki; Wara-aswapati, Nawarat; Chen, Yi-Wen; 郭彥彬; 王振穎; 陳漪紋; 許秉寧; 王政穎; 王姻麟 |
| 臺北醫學大學 |
2015-12 |
beta blocker
|
B313102035 |
| 國立臺灣大學 |
2000 |
Beta Cell Function Declines with Age in Glucose Tolerant Caucasians
|
邱建元; 莊立民; CHIU, KEN-C; CHUANG, LEE-MING |
| 臺大學術典藏 |
2018-09-10T03:32:00Z |
Beta cell function declines with age in glucose tolerant Caucasians
|
Chiu, K.C. and Lee, N.P. and Cohan, P. and Chuang, L.-M.; LEE-MING CHUANG |
| 臺大學術典藏 |
2020-06-01T04:30:36Z |
Beta cell function declines with age in glucose tolerant Caucasians
|
LEE-MING CHUANG;Cohan P.;Lee N.P.;Chiu K.C.; Chiu K.C.; Lee N.P.; Cohan P.; LEE-MING CHUANG |
| 國立臺灣大學 |
1978 |
Beta Decay and Muon Capture in the A=12 Nuclei:Second-Class Current and Conserved Vector Current
|
黃偉彥; Primakoff, H.; Hwang, Woei-Yann Pauchy; Primakoff, H. |
| 中國醫藥大學 |
2001-04-15 |
Beta Gauge與TEOM量側結果比較
|
郭錦堂(Ching-tang Kuo) |
| 國立東華大學 |
2004 |
Beta Instability of Firms: The Case of Taiwan Stock market during Its Financial Development
|
Chiao, Chaoshin; Hung, Ken; Nwanna, Gladson I. |
| 真理大學 |
2005-11 |
Beta Type 3 Distribution and Its Multivariate Generalization
|
Cardeño, Liliam; Nagar, Daya K.; Sánchez, Luz Estela |
| 國立臺灣大學 |
2008-10-31 |
Beta 死了嗎？ 時變 Beta 的檢定與估計
|
林建甫 |
